Welcome to Healthscope Molecular
Healthscope Molecular is one of the largest molecular pathology laboratories in Australia, performing more than 190,000 tests per annum, and is also the biotechnology division of Healthscope Limited.
As well as providing clinical molecular diagnostics to the Healthscope Pathology division, Healthscope Molecular also has a strong research and development commitment. Healthscope Molecular’s current research program focuses on the clinical utility of pharmacogenomics, an area of great excitement for the improvement of individualised drug selection and dosing. Another area of research is in the clinical application of genomics, particularly in reference to cancer diagnosis.
Healthscope Molecular currently has purpose built laboratories within Gribbles Pathology (Melbourne) that are accredited by the National Association of Testing Authorities (NATA) to the international standard, ISO17025, with assay validation based on NPACC standards and guidelines.
NEWS:
Oncotype DX®
Beginning 2009, Healthscope through Gribbles Pathology became a partner of Genomic Health, and can now assist both patients and doctors with Oncotype DX® testing.